Back

A reliability-screened thalamocortical control-network phenotype tracks cocaine-use history in cocaine use disorder

Edelman, B. B.; Skolnick, J.

2026-04-29 addiction medicine
10.64898/2026.04.28.26351962 medRxiv
Show abstract

BackgroundA central goal in psychiatry is to move from symptom-defined diagnoses toward biologically interpretable and reliable phenotypes. In cocaine use disorder (CUD), many resting-state abnormalities have been reported, but few circuit-level findings have been explicitly screened for reliability. We tested whether prespecified thalamocortical features yield a reproducible phenotype in CUD and whether that phenotype reflects diagnosis, recent cocaine use, or longer-term illness history. MethodsDiscovery analyses used resting-state data from 105 participants (46 healthy controls, 59 CUD). From a 13-region thalamocortical circuit, we derived an HC-trained LEiDA state model, generated 11 prespecified features, and advanced only those meeting split-half reliability criteria (ICC[3,1] [≥]0.40). A separate paired TMS sample (n=44) was used for extension analyses. ResultsFive features survived reliability screening. Within CUD, longer duration since beginning cocaine use was associated with greater occupancy of a control-like state (standardized {beta}=0.37, q=0.005) and stronger whole-thalamus connectivity with control frontoparietal cortex (standardized {beta}=0.30, q=0.018). Neither days since last use nor CUD vs. healthy diagnosis were associated with any reliable feature after correction. Joint-history models indicated that the signal was better explained by longer-term use history than by recent use. Localization analyses indicated the connectivity effect was concentrated in dorsal thalamic regions. TMS-interaction and effective-connectivity follow-ups were null. ConclusionsReliability screening identified a thalamocortical control-network phenotype in CUD that tracks longer cocaine-use history rather than diagnosis or recent use. More broadly, this workflow offers a practical framework for screening candidate circuit-level psychiatric phenotypes for reliability.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Translational Psychiatry
260 papers in training set
Top 0.2%
14.5%
2
Nature Mental Health
21 papers in training set
Top 0.1%
12.2%
3
Biological Psychiatry
137 papers in training set
Top 0.2%
9.4%
4
American Journal of Psychiatry
24 papers in training set
Top 0.1%
9.3%
5
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
71 papers in training set
Top 0.1%
9.3%
50% of probability mass above
6
Drug and Alcohol Dependence
41 papers in training set
Top 0.2%
5.3%
7
Neuropsychopharmacology
153 papers in training set
Top 0.6%
5.3%
8
The British Journal of Psychiatry
23 papers in training set
Top 0.1%
4.7%
9
Biological Psychiatry Global Open Science
60 papers in training set
Top 0.3%
3.9%
10
Addiction Biology
51 papers in training set
Top 0.3%
3.1%
11
Human Brain Mapping
329 papers in training set
Top 2%
2.6%
12
Frontiers in Psychiatry
87 papers in training set
Top 0.9%
2.3%
13
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.5%
1.7%
14
Brain Communications
166 papers in training set
Top 2%
1.4%
15
JAMA Network Open
130 papers in training set
Top 3%
1.1%
16
Brain
168 papers in training set
Top 3%
1.1%
17
Communications Biology
993 papers in training set
Top 27%
1.0%
18
The Journal of Neuroscience
1025 papers in training set
Top 9%
1.0%
19
NeuroImage: Clinical
144 papers in training set
Top 2%
0.9%
20
Psychological Medicine
88 papers in training set
Top 2%
0.8%
21
PLOS ONE
5266 papers in training set
Top 63%
0.8%
22
Brain and Behavior
43 papers in training set
Top 2%
0.6%
23
Psychopharmacology
69 papers in training set
Top 0.9%
0.6%
24
JAMA Psychiatry
15 papers in training set
Top 0.6%
0.6%